Evaluating the Urinary Exosome MicroRNA Profile in Prostate Cancer
Genes · 15.07.2026 · 17 (7) · 802
DOI: 10.3390/genes17070802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 15.07.2026. Verfasst von Beatriz Walter Rodriguez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Exosomes, MicroRNAs, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background/Objectives: Prostate cancer is the second most frequent cancer among men and the 5th leading cause of cancer death among men worldwide. Identification of urine-derived biomarkers, such as exosomal miRNAs, in liquid biopsies for prostate cancer could be very beneficial for screening and active surveillance.
Methods
Urine was collected from 42 patients with biopsy-proven evidence of prostate cancer and exosomes were extracted. Transcriptomic analysis was performed on the urine-derived exosomal miRNA and compared to the urine-derived exosomal miRNA profiles from 10 normal control donors and 15 von Hippel-Lindau (VHL) syndrome patients with clear cell renal cell carcinoma (ccRCC).
Results
Urine-derived exosomal miRNA profiles of prostate patients were significantly different from normal control individuals. Significantly increased expression of miR-122-5p and decreased expression of miR-125-5p and miR-16-5p were observed in the urine-derived exosomes from prostate cancer patients. Significant upregulation of miR-30a-5p and downregulation of miR-320-5p, miR-320b, and miR-320c were observed in the urine-derived exosomes from both prostate cancer patients and VHL patients with ccRCC, indicating these miRNAs could be non-specific markers of urological cancer. Increased expression of miR-10a-5p and miR-30e-5p or miR-532-5p and miR-206 correlated with the presence of either extracapsular or perineural invasion, respectively.
Conclusions
This study highlights the potential for urine-derived exosomal miRNA profiles to identify the presence of prostate cancer and predict clinical features, additionally showing that miRNA signals could be non-specific markers of urologic cancer types. Further validation studies are necessary to demonstrate the utility of urine-derived exosomal miRNA profiles as biomarkers for diagnosis or prognosis in prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Christopher J Ricketts
Förderung
- Intramural NIH HHS
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Walter Rodriguez, B., Ricketts, C. J., Turkbey, B., Pinto, P. A., & Merino, M. J. (2026). Evaluating the Urinary Exosome MicroRNA Profile in Prostate Cancer. Genes, 17(7), 802. https://doi.org/10.3390/genes17070802
Vancouver
Walter Rodriguez B, Ricketts CJ, Turkbey B, Pinto PA, Merino MJ. Evaluating the Urinary Exosome MicroRNA Profile in Prostate Cancer. Genes. 2026;17(7):802. doi:10.3390/genes17070802
BibTeX
@article{WalterRodriguez2026,
author = {Walter Rodriguez, Beatriz and Ricketts, Christopher J and Turkbey, Baris and Pinto, Peter A and Merino, Maria J},
title = {Evaluating the Urinary Exosome MicroRNA Profile in Prostate Cancer},
journal = {Genes},
year = {2026},
volume = {17},
number = {7},
pages = {802},
doi = {10.3390/genes17070802}
}
EUVIMED